Cargando…
Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis
BACKGROUND: Juvenile pulmonary alveolar proteinosis (PAP) due to CSF2RA mutations is a rare disorder with only a few cases described worldwide. METHODS: We identified nine children with severe diffuse interstitial lung disease due to CSF2RA mutations. Clinical course, diagnostic findings and treatme...
Autores principales: | Hildebrandt, Jenna, Yalcin, Ebru, Bresser, Hans-Georg, Cinel, Guzin, Gappa, Monika, Haghighi, Alireza, Kiper, Nural, Khalilzadeh, Soheila, Reiter, Karl, Sayer, John, Schwerk, Nicolaus, Sibbersen, Anke, Van Daele, Sabine, Nübling, Georg, Lohse, Peter, Griese, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254258/ https://www.ncbi.nlm.nih.gov/pubmed/25425184 http://dx.doi.org/10.1186/s13023-014-0171-z |
Ejemplares similares
-
Long-term follow-up and treatment of congenital alveolar proteinosis
por: Griese, Matthias, et al.
Publicado: (2011) -
Autoimmune pulmonary alveolar proteinosis in children
por: Griese, Matthias, et al.
Publicado: (2022) -
Minimal important difference in childhood interstitial lung diseases
por: Griese, Matthias, et al.
Publicado: (2023) -
Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA
por: Suzuki, Takuji, et al.
Publicado: (2008) -
Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial
por: Griese, Matthias, et al.
Publicado: (2020)